Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Adverse Prognostic Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Diffuse Large B Cell Lymphoma

Sun-Young Kong, MD PhD, Hyewon Lee, MD, Ji Yeon Sohn, MD, Hyeon-Seok Eom

Blood (2014) 124 (21): 5410.

https://doi.org/10.1182/blood.V124.21.5410.5410

Published: 2014

Journal Articles

Mimicking Myeloma Niche Ex Vivo

Jana Jakubikova, PhD, Danka Cholujova, PhD, Richard W Groen, PhD, Jungnam Joo, PhD, Sun-Young Kong, MD PhD, Teru Hideshima, MD PhD, Rikio Suzuki, MDPhD, Jan Sedlak, PhD, Constantine S Mitsiades, MD PhD, David M Dorfman, MD PhD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Paul G. Richardson, MD PhD, Kenneth Anderson, MD PhD

Blood (2014) 124 (21): 2076.

https://doi.org/10.1182/blood.V124.21.2076.2076

Published: 2014

Journal Articles

Hematopoietic Progenitor Cell Counts Is a Useful Indicator To Determine Appropriate Time For Peripheral Blood Stem Cell Collection

Sun-Young Kong, MD&PhD, Hyoeun Shim, MD, Se-Na Lee, Jung-Hee Kong, Hyeon-Seok Eom, MD&PhD, Byung-Kiu Park, MD&PhD, Hyeon Jin Park, MD&PhD, Tak Yun, MD&PhD, Hyewon Lee, MD, Yoon Kyung Song

Blood (2013) 122 (21): 2037.

https://doi.org/10.1182/blood.V122.21.2037.2037

Published: 2013

Journal Articles

Prognostic Implication Of Circulating Vascular Endothelial Growth Factor In Patients With Diffuse Large B-Cell Lymphoma

Hyewon Lee, MD, Hyeon-Seok Eom, MD&PhD, Min Kyeong Kim, Hyun-Ju Kim, Weon Seo Park, Sun-Young Kong, MD&PhD

Blood (2013) 122 (21): 3007.

https://doi.org/10.1182/blood.V122.21.3007.3007

Published: 2013

Journal Articles

Adverse Prognostic Impact of Vascular Endothelial Growth Factor Gene Polymorphism in Patients with Non-Hodgkin Lymphoma.

Min Kyeong Kim, Hyeon Seok Eom, MD, Hyewon Lee, Mi Hwa Han, Hyun-Ju Kim, Weon Seo Park, Tak Yun, Sun-Young Kong

Blood (2012) 120 (21): 2674.

https://doi.org/10.1182/blood.V120.21.2674.2674

Published: 2012

Journal Articles

Targeting NAD + salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

Michele Cea, Antonia Cagnetta, Mariateresa Fulciniti, Yu-Tzu Tai, Teru Hideshima, Dharminder Chauhan, Aldo Roccaro, Antonio Sacco, Teresa Calimeri, Francesca Cottini, Jana Jakubikova, Sun-Young Kong, Franco Patrone, Alessio Nencioni, Marco Gobbi, Paul Richardson, Nikhil Munshi, Kenneth C. Anderson

Blood (2012) 120 (17): 3519–3529.

https://doi.org/10.1182/blood-2012-03-416776

Published: 2012

Includes: Supplemental data

Journal Articles

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

Blood (2012) 120 (9): 1877–1887.

https://doi.org/10.1182/blood-2011-12-396853

Published: 2012

Includes: Supplemental data

Journal Articles

Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function

Yu-Tzu Tai, Holly M. Horton, Sun-Young Kong, Erik Pong, Hsing Chen, Saso Cemerski, Matthew J. Bernett, Duc-Hanh T. Nguyen, Sher Karki, Seung Y. Chu, Greg A. Lazar, Nikhil C. Munshi, John R. Desjarlais, Kenneth C. Anderson, Umesh S. Muchhal

Blood (2012) 119 (9): 2074–2082.

https://doi.org/10.1182/blood-2011-06-364521

Published: 2012

Includes: Supplemental data

Journal Articles

Targeting Brouton's Tyrosine Kinase with PCI-32765 Blocks Growth and Survival of Multiple Myeloma and Waldenström Macroglobulinemia Via Potent Inhibition of Osteoclastogenesis, Cytokines/Chemokine Secretion, and Myeloma Stem-Like Cells in the Bone Marrow Microenvironment

Blood (2011) 118 (21): 883.

https://doi.org/10.1182/blood.V118.21.883.883

Published: 2011

Journal Articles

Blockade of Nuclear Export Protein CRM1 (chromosomal region maintenance 1, XPO1) by a Novel, Potent and Selective CRM1 Inhibitor KPT-185 Induces Significant Antitumor Activity Against Human Multiple Myeloma

Sun-Young Kong, MD, PhD, Yosef Landesman, PhD, Jana Jakubikova, PhD, Michael A. Sellitto, Antonia Cagnetta, MD, Michele Cea, MD, Michelle C. Chen, Francesca Cottini, MD, Douglas W. McMillin, PhD, Chirag Acharya, MD, William Senapedis, PhD, Sharon Shacham, PhD, MBA, Michael Kauffman, MD, PhD, Dilara McCauley, PhD, Jean-Richard Saint-Martin, BS, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Yu-Tzu Tai, PhD

Blood (2011) 118 (21): 2913.

https://doi.org/10.1182/blood.V118.21.2913.2913

Published: 2011

Journal Articles

Targeting NAD + Salvage Pathway Induces Autophagy in Multiple Myeloma Cells

Michele Cea, MD, Antonia Cagnetta, MD, Yu-Tzu Tai, PhD, Mariateresa Fulciniti, PhD, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Sun-Young Kong, MD, PhD, Teresa Calimeri, M.D., Francesca Cottini, MD, Jana Jakubikova, PhD, Alessio Nencioni, Marco Gobbi, MD, Franco Patrone, Kenneth C. Anderson, MD

Blood (2011) 118 (21): 2920.

https://doi.org/10.1182/blood.V118.21.2920.2920

Published: 2011

Journal Articles

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

Jana Jakubikova, Sophia Adamia, Maria Kost-Alimova, Steffen Klippel, David Cervi, John F. Daley, Dana Cholujova, Sun-Young Kong, Merav Leiba, Simona Blotta, Melissa Ooi, Jake Delmore, Jacob Laubach, Paul G. Richardson, Jan Sedlak, Kenneth C. Anderson, Constantine S. Mitsiades

Blood (2011) 117 (17): 4409–4419.

https://doi.org/10.1182/blood-2010-02-267344

Published: 2011

Includes: Supplemental data

Journal Articles

VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma

Min Kyoung Kim, Cheolwon Suh, MD, Hyun Sook Chi, Hee Soon Cho, Kyung Hee Lee, Gyeong-Won Lee, In-Suk Kim, MD, PhD, Hyeon Seok Eom, Sun-Young Kong, MD, PhD, Sung Hwa Bae, Hun-Mo Ryoo, MD, PhD, Yeung-Chul Mun, MD, PhD, Hwasoon Chung, Myung Soo Hyun

Blood (2010) 116 (21): 994.

https://doi.org/10.1182/blood.V116.21.994.994

Published: 2010

Journal Articles

Prognostic Significance of Immune Thrombocytopenic Purpura In Patients with Malignancy.

Hyojeong Kim, Hyeon-Seok Eom, Sun-Young Kong, MD, PhD, Sook Ryun Park, Sun Young Kim, Jungsil Ro, Sang-Yoon Park

Blood (2010) 116 (21): 1428.

https://doi.org/10.1182/blood.V116.21.1428.1428

Published: 2010

Journal Articles

Lenalidomide Enhances Multiple Myeloma Cytotoxicity Induced by a Novel Fc Domain-Engineered Anti-HM1.24 Monoclonal Antibody with Augmented NK Cell Degranulation

Sun-Young Kong, MD, PhD, Sabikun Nahar, Xian-Feng Li, Weihua Song, MD, Yiguo Hu, Umesh Muchhal, John Desjarlais, Paul Richardson, M.D., Ph.D., Nikhil C. Munshi, MD, Kenneth C. Anderson, Yu-Tzu Tai, PhD

Blood (2010) 116 (21): 4064.

https://doi.org/10.1182/blood.V116.21.4064.4064

Published: 2010

Journal Articles

Daratumumab Directly Induces Human Multiple Myeloma Cell Death and Acts Synergistically with Conventional and Novel Anti-Myeloma Drugs

Sun-Young Kong, MD, PhD, Xian-Feng Li, Sabikun Nahar, Weihua Song, MD, Michel de Weers, Paul W.H.I. Parren, Paul Richardson, M.D., Ph.D., Nikhil C. Munshi, MD, Kenneth C. Anderson, Yu-Tzu Tai, PhD

Blood (2010) 116 (21): 3013.

https://doi.org/10.1182/blood.V116.21.3013.3013

Published: 2010

Journal Articles

Fluorescent in Situ Hybridization Analysis at Bone Marrow Biopsy Section in Multiple Myeloma.

Eun Hae Cho, Sang-Mi Lee, Hyeon-Seok Eom, In-Suk Kim, Gyeong-Won Lee, Sun-Young Kong

Blood (2009) 114 (22): 4898.

https://doi.org/10.1182/blood.V114.22.4898.4898

Published: 2009

Journal Articles

DNA Repair Gene, XRCC1 P olymorphisms Are Associated with Chemotherapy Induced Toxicity in Patients with Diffuse Large B Cell Lymphoma Who Received Frontline R-CHOP Chemotherapy.

In-Suk Kim, Gyeong-Won Lee, Hoon-Gu Kim, Sun-Young Kong, MD, PhD, HyeonSeok Eom, MD, PhD

Blood (2008) 112 (11): 1620.

https://doi.org/10.1182/blood.V112.11.1620.1620

Published: 2008

NARROW

Adverse Prognostic Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Diffuse Large B Cell Lymphoma

Mimicking Myeloma Niche Ex Vivo

Hematopoietic Progenitor Cell Counts Is a Useful Indicator To Determine Appropriate Time For Peripheral Blood Stem Cell Collection

Prognostic Implication Of Circulating Vascular Endothelial Growth Factor In Patients With Diffuse Large B-Cell Lymphoma

Adverse Prognostic Impact of Vascular Endothelial Growth Factor Gene Polymorphism in Patients with Non-Hodgkin Lymphoma.

Targeting NAD + salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function

Targeting Brouton's Tyrosine Kinase with PCI-32765 Blocks Growth and Survival of Multiple Myeloma and Waldenström Macroglobulinemia Via Potent Inhibition of Osteoclastogenesis, Cytokines/Chemokine Secretion, and Myeloma Stem-Like Cells in the Bone Marrow Microenvironment

Blockade of Nuclear Export Protein CRM1 (chromosomal region maintenance 1, XPO1) by a Novel, Potent and Selective CRM1 Inhibitor KPT-185 Induces Significant Antitumor Activity Against Human Multiple Myeloma

Targeting NAD + Salvage Pathway Induces Autophagy in Multiple Myeloma Cells

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma

Prognostic Significance of Immune Thrombocytopenic Purpura In Patients with Malignancy.

Lenalidomide Enhances Multiple Myeloma Cytotoxicity Induced by a Novel Fc Domain-Engineered Anti-HM1.24 Monoclonal Antibody with Augmented NK Cell Degranulation

Daratumumab Directly Induces Human Multiple Myeloma Cell Death and Acts Synergistically with Conventional and Novel Anti-Myeloma Drugs

Fluorescent in Situ Hybridization Analysis at Bone Marrow Biopsy Section in Multiple Myeloma.

DNA Repair Gene, XRCC1 P olymorphisms Are Associated with Chemotherapy Induced Toxicity in Patients with Diffuse Large B Cell Lymphoma Who Received Frontline R-CHOP Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only